The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Senior US general warns of possible looming war with China

  • 3

    Suicidal pedestrian saved over Han River bridge

  • 5

    Opposition leader Lee claims innocence in corruption probe

  • 7

    US four-star general warns of war with China in 2025

  • 9

    NK rejects alleged arms trading with Russia, warns of 'undesirable result'

  • 11

    INTERVIEWBusan has potential to be world-class city, says mayor

  • 13

    Youth, foreign drug offenders increase threefold in 5 years

  • 15

    US secures deal with Netherlands, Japan on limiting chip exports to China: Bloomberg

  • 17

    White House highlights cryptocurrency risks, citing N. Korean cyber theft

  • 19

    Samsung to introduce low-carbon diet for employees to help tackle climate change

  • 2

    Japanese teen romance film attracts 1 mil. Korean viewers for 1st time in 21 yrs

  • 4

    Korea to lift indoor mask mandate Monday

  • 6

    To speak Korean

  • 8

    Cambodian ministers highlight potential for growth, cooperation

  • 10

    Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity'

  • 12

    Tyre Nichols' brutal beating by police shown on video

  • 14

    Japan launches whale meat vending machines to promote sales

  • 16

    UN rapporteur for N. Korea human rights to visit S. Korea next week

  • 18

    Japan eyes easing export controls on Korea as Seoul seeks to improve ties: media

  • 20

    3 dead, 4 hurt in upmarket Los Angeles neighborhood

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Mon, January 30, 2023 | 11:32
Health & Science
Korea seeks to secure additional COVID-19 pills from Pfizer
Posted : 2021-12-23 16:36
Updated : 2021-12-24 14:01
Lee Hyo-jin
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Paxlovid, Pfizer's COVID-19 treatment pill, is seen being packaged in Ascoli, Italy, in this undated handout photo, Nov. 16. Reuters-Yonhap
Paxlovid, Pfizer's COVID-19 treatment pill, is seen being packaged in Ascoli, Italy, in this undated handout photo, Nov. 16. Reuters-Yonhap

Korea reports 109 COVID-19 deaths, first triple-digit toll

By Lee Hyo-jin

The Korean government seeks to secure an additional supply of Pfizer's oral COVID-19 treatment, after the pill became the first oral antiviral drug to have been cleared by the U.S. drug regulator during the pandemic.

"We are closely discussing with Pfizer supply deals additional to the pills for 70,000 people that we have already purchased," Kim Ok-soo, a senior official at the Korea Disease Control and Prevention Agency (KDCA), said during a briefing, Thursday.

"Details on shipment schedules, the supply amount and whom they will be used on will be announced later, in accordance with the emergency authorization approval from the Ministry of Food and Drug Safety."

If introduced, the pills will be used in treating COVID-19 patients undergoing home treatment, patients of high-risk groups as well as those showing mild and moderate symptoms, Kim said.

The announcement came after the U.S. Food and Drug Administration (FDA) granted emergency authorization for Pfizer's oral drug Paxlovid, Wednesday (local time).

The FDA has given the pill the green light for COVID-19 patients aged 12 and older with mild to moderate symptoms. It should be prescribed as soon as possible after a COVID-19 diagnosis and within five days of symptom onset, the FDA said.

Paxlovid is given as three co-packaged tablets: two nirmatrelvir tablets and one ritonavir tablet.

The oral drug has been widely anticipated by many experts as a possible "game changer" in the battle against the pandemic, considering its efficacy, relatively low price and ease of administration. All of the previously approved COVID-19 treatments required either an injection or intravenous (IV) infusion.

The results from Pfizer's study, involving more than 2,200 people at high risk for developing serious COVID-19 illness, found that the pill reduced the risk of hospitalization or death by 89 percent, when taken within three days of the first symptoms of illness. When taken within five days, the drug reduced the risk of hospitalization and death by 88 percent.

Paxlovid, Pfizer's COVID-19 treatment pill, is seen being packaged in Ascoli, Italy, in this undated handout photo, Nov. 16. Reuters-Yonhap
Healthcare workers dressed up in Santa Claus costumes prepare to administer coronavirus tests at a testing center in Gwangju, Thursday. Yonhap

The Korean government said earlier that it plans to secure enough coronavirus treatment pills for 404,000 patients, to be introduced gradually starting in February.

In addition to the deal with Pfizer, it has made an agreement with Merck to purchase enough of its oral drug molnupiravir for 242,000 people. From which company it will purchase the remaining amount is under discussion, the KDCA said.

The Ministry of Food and Drug Safety, for its part, said that it has launched a review for emergency authorization of the Pfizer pill, upon the request of the KDCA.

Meanwhile, Korea is battling its worst COVID-19 crisis yet, as the country saw record-breaking numbers of critical cases and deaths for Wednesday.

According to the KDCA, the number of critically ill patients and deaths reached all-time highs on Wednesday, at 1,083 and 109, respectively. There were 6,919 new infections, raising the aggregated total to 589,978.

Twelve new cases of the Omicron variant were identified, raising the total number of infections to 246. In just three weeks after the country detected it first cases of the variant on Dec. 1 in Incheon, the variant has spread rapidly across major cities, including Seoul, Daegu and the southwestern city of Gwangju.


Emaillhj@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Suicidal pedestrian saved over Han River bridge Suicidal pedestrian saved over Han River bridge
2Korea to lift indoor mask mandate Monday Korea to lift indoor mask mandate Monday
3[INTERVIEW] Busan has potential to be world-class city, says mayor INTERVIEWBusan has potential to be world-class city, says mayor
4Youth, foreign drug offenders increase threefold in 5 years Youth, foreign drug offenders increase threefold in 5 years
5Samsung to introduce low-carbon diet for employees to help tackle climate change Samsung to introduce low-carbon diet for employees to help tackle climate change
6Seoul International School celebrates 50th anniversary Seoul International School celebrates 50th anniversary
7Plum trees, pheasants and promises of old Korea Plum trees, pheasants and promises of old Korea
8Main opposition leader faces pressure to resign in case of indictment Main opposition leader faces pressure to resign in case of indictment
9Bank operating hours return to normal amid union opposition Bank operating hours return to normal amid union opposition
10Samsung begins 9th software developer training school Samsung begins 9th software developer training school
Top 5 Entertainment News
1BLACKPINK sets 6 more Guinness records BLACKPINK sets 6 more Guinness records
2Jang Keun-suk steps out of his comfort zone with 'The Bait' Jang Keun-suk steps out of his comfort zone with 'The Bait'
3ENA's new dating show to spotlight young adult's romance ENA's new dating show to spotlight young adult's romance
4TXT brings together 'pansori' and fairy tale in new song 'Sugar Rush Ride' TXT brings together 'pansori' and fairy tale in new song 'Sugar Rush Ride'
5Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity' Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity'
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group